. Author manuscript; available in PMC: 2010 Oct 1.

Published in final edited form as: Clin Cancer Res. 2008 Jul 1;14(13):4128–4133. doi: 10.1158/1078-0432.CCR-07-5160

Table 4.

Multivariate analysis of OS (n = 379)

Variable	HR (95% CI)	P^*
Bad + Bid (high vs low)	0.57 (0.40–0.82)	0.0038
Histologic grade (3, 4 vs 1, 2)^†	1.69 (1.21–2.36)	0.0025
TNM stage (III vs II)	1.84 (1.12–3.03)	0.0101
Treatment (effective vs ineffective)	0.61 (0.38–0.96)	0.0354
Age (≤65 vs >65 y)	0.86 (0.62–1.20)	0.3779

Likelihood ratio P, adjusted for histologic grade, tumor stage, treatment, age, and study.

^†

1, 2 (well/moderate) and 3, 4 (poor/undifferentiated).